The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Betting markets take a 2% tax on Trump

Mon, 28th Sep 2020 14:26

* European shares rebound

* Banks lead sectoral gainers, up 4.6%

* Eyes on William Hill after bid proposal

* Wall St futures higher
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) and Danilo Masoni (danilo.masoni@thomsonreuters.com) in
Milan.

BETTING MARKETS TAKE A 2% TAX ON TRUMP (1324 GMT)

There are only two certainties in this life, death and taxes, Benjamin Franklin famously
wrote.

While Trump may not have paid a large amount in taxes according to the NYT, there seems to
be a different kind of taxman https://bit.ly/3ja0PDZ coming his way in the form of betting
markets.

The implied probability of him winning this year's U.S. Presidential election fell to 43%
overnight on the news, down 2 percentage points, as per Betfair Exchange data.

Trump has already dismissed as "fake news" the NYT report which, citing tax-return data,
said the President forked out a grand total of $750 in federal income taxes in both 2016 and
2017.

Anyhow, it's worth remembering that Trump defied betting markets before. He was billed at
just 33% the implied probability to win the 2016 election on the eve of the first debate that
year, Betfair Exchange data shows.

He's still far above that ahead of Tuesday's first of three debates with Joe Biden.

Looking for an earworm? Here's a link to The Beatles song complaining about their tax bill
back in the 60s: https://bit.ly/3ja0PDZ

(Aaron Saldanha)

*****

EQUITIES STILL CHOPPY, BUT THEN A VACCINE ... (1304 GMT)

We shouldn’t worry about European equities as a recent choppy and sometimes unpredictable
trend might not last long.

Despite surging coronavirus cases coupled with concerns about the economic recovery, Morgan
Stanley sees some light at the end of the tunnel as a vaccine is about to come.

September was tricky if not scary as the market had to digest uncertainty related to fresh
U.S. fiscal stimulus, Brexit and the coronavirus outbreak.

“With each of these issues remaining ‘live’ in the near term” MS expects stocks to remain
choppy for a while, a research note says, adding they are not oversold yet.

The medium term outlook is a positive one as Morgan Stanley expects possible good news on
the vaccine front in Q4.

Morgan Stanley analysts expect “pivotal data for three covid-19 vaccines to begin reporting
in October or November.”

The AstraZeneca vaccine is most important as it has a "potential for 700 million
doses to be available by the end of 2020 (three billion doses by the end of 2021), which opens
up the possibility of mass vaccination programs starting as early as 1Q21."

(Stefano Rebaudo)

*****

DANCING WITH THE BOE, HUMMING WITH BREXIT (1227 GMT)

Who said Mondays are dull?

There's music and dancing across the UK newsflow today with both Brexit and negative rates
providing some background entertainment for the rising pound.

First, as noted by Gilles Moëc, chief economist at AXA Investment Managers, there's
"positive mood music in the British press on the chances of a Free Trade Agreement between
London and Brussels."

Funny to note that we also got an EU diplomat using the same expression in a story today
.

"The mood music was a bit better", that diplomat said, noting Britain's Brexit supremo
Gove's confidence about securing a deal, which came after Barnier's said he was determined to
clinch an agreement last week.

As for the dancing, it's provided courtesy of the BoE!

BoE policymaker Silvana Tenreyro defended negative rates in a newspaper interview over the
weekend, a move which Neil Wilson at Markets.com called "a careful piece of choreography to
communicate the bank’s shift towards a state of outright financial repression".

If the BoE is indeed dancing one step forward, one step backward, then Bank of England
Deputy Governor Dave Ramsden surely qualifies as a good tango partner.

"For me, I see the effective lower bound still at 0.1 which is where Bank Rate is at
present," Ramsden said in an interview with Britain's Society of Professional Economists posted
online today.

So while BoE rate setters are blowing hot and cold on negative rates, there's a lot being
written about the possible impact of negative rates.

George Lagarias, chief economist at Mazars, for instance sees the strategy as a double-edged
sword which on one hand could help prevent an vicious economic cycle, but which could on the
other hand be devastating for the balance sheets of British banks.

"European Banks, who for years have endured negative rates and have been one of the worst
sectors globally, can attest to that", he said, adding that investors might decide not to jump
into risky investments despite the policy change.

And that's actually the point of a Reuters analysis published earlier this month which
showed that negative rates can be ineffectual and perhaps even counterproductive.

Here's the story:

ANALYSIS-"Don't do it" -studies flash sub-zero rate warnings to central banks

And more reading:

Britain, EU start key week of Brexit talks with 'better mood music'

UPDATE 2-Bank of England's Ramsden sees floor for rates above zero

UPDATE 1-BoE's Tenreyro says evidence on negative rates is "encouraging"

(Julien Ponthus and Elizabeth Howcroft)

*****

WORRIED ABOUT A STRONGER DOLLAR? BET ON DRUGS (1041 GMT)

Over the last 15 years there looks to have been an inverse correlation between global stocks
and the dollar, and if history is any guide, the recent signs of the greenback bottoming out may
not be a good omen.

"This is especially if the USD rebound is coupled with stalling PMIs, as seen last week in
Europe, a rollover in EPS revisions, weaker oil price, peaking inflation breakevens, as well as
bond yields remaining stuck in a range," JPMorgan says.

But of course there are exceptions, namely EU exporters, and at this point it time,
strategists at the U.S. bank say they're "particularly bullish" on healthcare.

European healthcare makes 71% of its revenues abroad, its performance has historically been
closely aligned to the dollar, and currently the sector is enjoying cheap valuations and strong
earnings momentum, JPMorgan notes.

(Danilo Masoni)

*****

GOLD MIGHT BE READY TO SHINE AGAIN (0954 GMT)

It doesn’t seem to be the case this morning with European stocks showing strong resilience
after the banking index hit an all-time low on Friday, but some analysts say risk sentiment is
low and suggest adding gold to portfolios.

According to UBS, gold staged a temporary correction but it could reach the $2,000/oz mark
by year end.

The investment bank mentions three reasons, which will favour the yellow metal while
weakening the U.S. dollar in the near future.

First with U.S. election looming and after the battle over the Supreme Court nomination the
chances of approval of a fresh stimulus package are abating and this will push the Fed to keep
interest rates low for longer.

Then a contested outcome is possible in the U.S. election “which could add to further
volatility and result in safe-haven flows, though more into gold, the Swiss franc, and the
Japanese yen than the US dollar,” a UBS research note says.

Since gold is priced in U.S. dollar, a greenback fall supports the yellow metal.

Besides central banks are ready to tolerate higher inflation and gold offers an hedge
against it “as a ‘real asset’.”

Below gold and dollar moving the opposite direction during summer

(Stefano Rebaudo)

*****

TACTICAL ON CYCLICALS (0928 GMT)

Looking at cyclicals rallying this morning across Europe, the idea to cool off exposure
might sound rather counter-intuitive.

But according to Sylvain Goyon, a strategist at Oddo, "it not absurd to consider a tactical
pause" given that the market might start worrying about the resurgence of the pandemic and the
curve of the V-shaped recovery losing steam amid disappointing PMIs.

Say you actually fear the economy is losing momentum and feel it is indeed time to sell some
exposure, what should you do with the cash?

Why not buy a long position on the VIX which would stretch beyond the U.S. November
election, asks Goyon who nevertheless stresses that the thing about a tactical retreat is that
it is, by definition, a temporary move.

"Neither the pandemic nor the electoral suspense in the U.S. invalidate the drivers behind
our call on valuation convergence in favor of cyclicals versus defensive and value versus
growth".

(Julien Ponthus)

*****

BANKS REBOUND FROM RECORD LOWS, BARGAIN HUNTERS BUYING THE DIP (0839 GMT)

European equities are staging a broad bounce-back this morning with all sectors trading in
the black, as it seems investors are hunting for bargains following Friday's sell-off.

And talking about bargains, banks spring to mind, so it's not a big surprise to see
them leading the advance with a 4% surge.

But if you put today's rally in the context of the sector hitting its latest new record low
on Friday, there's much less to rejoice about. And with the prospect of interest rates staying
lower for longer, any quick reversal in the industry's fortunes just looks highly unlikely.

And here you can see how cheap are European banks, currently trading at a record low
price-to-book value of less than 0.5.

(Danilo Masoni)

*****

OPENING SNAPSHOT: STRONG REBOUND, BANKS SHINE (0739 GMT)

European stocks are higher as newsflow on the M&A front as well as on some banks is
supporting a rebound after recent falls.

ArcelorMittal shares are up 6% after striking a deal to sell its U.S. assets, while
shares in Commerzbank are up 4.8% as the nomination of the new CEO paves the way for
an overhaul that could close hundreds of branches and shrink its foreign operations.

HSBC stocks, up 9.8%, are following the gains of Hong Kong listed shares,
after the bank’s biggest shareholder Ping An Insurance Group Co of China bought additional
shares in the British bank to take its stake to 8% from 7.95%.

The STOXX 600 is up 1.5%, with banking stock index up 4.2%, after hitting a fresh
all-time low on Friday.

Almost a mute reaction by Suez shares, up 0.8%, after Veolia said it would improve
its offer.

William Hill stocks are down 10% after Friday’s jump, as Caesars Entertainment
said it was in advanced talks about a possible cash offer that values the British
bookmaker at about 2.9 billion pounds.

Risk sentiment is showing some resilience as investors focus on stimulus plans by
governments and central banks.

(Stefano Rebaudo)

*****

ON THE RADAR: M&A ON THE FRONTLINE, COMMERZBANK (0640 GMT)

European stocks are poised to open higher supported by a tech shares rebound on Wall Street
on Friday and strong Chinese data during the weekend.

Risk sentiment continues to show some resilience as investors are focused on stimulus plans
by governments and central banks.

Cleveland-Cliffs, the largest U.S. producer of iron ore pellets, said it had agreed
to buy the U.S. assets of world's largest steelmaker ArcelorMittal for about $1.4
billion.

U.S. casino operator Caesars Entertainment said it was in advanced talks with
William Hill about a possible cash offer that values the British bookmaker at about 2.9
billion pounds.

French utility group Veolia will improve its offer to buy the bulk of Engie's
stake in smaller rival Suez by September 30. Veolia last month offered 2.9
billion euros for a 29.9% stake in Suez owned by Engie, with a view to subsequently taking full
control of Suez by buying up more shares.

Shares in Commerzbank are up 4.4% in early trade after the nomination of Manfred
Knof as chief executive of Germany's bank, which paves the way for an overhaul that could close
hundreds of branches and shrink its foreign operations, though any major changes may still take
months to formalise.

Investors welcomed former Daimler chief executive Dieter Zetsche's decision to
forego his role as chairman of the German carmaker, announced at the weekend and starting a race
to find an independent head of the company's supervisory board.

Rio Tinto is willing to continue talks with the New Zealand government on
extending operations at its Tiwai Point aluminium smelter.

Sonova expects to return to growth in the second half of the year.

Eyes also on Diageo which said its business was performing ahead of its
expectations.

(Stefano Rebaudo)

*****

MORNING CALL: RESILIENT AFTER RECENT FALLS (0533 GMT)

European stock futures are well in the black showing some resilience after recent falls and
a tech shares rebound on Wall Street on Friday, though broad sentiment remain cautious.

Asian stocks are higher after profits at China’s industrial firms grew for the fourth
straight month in August, but concerns about surging coronavirus cases in Europe and risks of
new restrictive measures continue to weigh.

However there is more going on as investors’ focus is on UK-Europe post-Brexit trade talks
and a fresh U.S. stimulus package, which by the way seems increasingly unlikely to be approved
before the November presidential election.

(Stefano Rebaudo)

*****

More News
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.